Insights

Vivek Kaul, MD, discusses how effective colorectal cancer screening is crucial for preventing late-stage disease, highlightsing current guidelines and, available screening options, and talks about the importance of patient communication in the decision-making process.

Jean-Frederic Colombel, MD, provides a comprehensive overview of subcutaneous infliximab-dyyb injection for ulcerative colitis and Crohn's disease, analyzing clinical trial data, , discussing patient selection for this therapy, and evaluating its place in the evolving inflammatory bowel disease treatment landscape.

Wendy Wright, DNP, examines the impact of fibromyalgia on patients, evaluates existing treatment options, and explores the implications of long-term medication use for managing this chronic condition.

Dennis Marcus, MD, analyzes anti-VEGF utilization through surgical intervention in patients with neovascular AMD.

Shawn Kwatra, MD, provides clinical insights on how patient-reported incomes can improve quality of life in patients with atopic dermatitis.

Ruth Ann Vleugels, MD, MPH, MBA, provides comprehensive insights on the treatment of patients with atopic dermatitis, focusing on the role of JAK inhibitors in the treatment paradigm.

Christopher Bunick, MD, PhD, discusses the management of moderate to severe atopic dermatitis, including the use of systemic treatments, the importance of patient-reported outcomes in clinical trials and patient care, and advice for clinicians on developing comprehensive treatment plans.

Anjali Tiku Owens, MD, emphasizes the role of novel Cardiac Myosin inhibitors (CMI) in the treatment of patients with obstructive hypertrophic cardiomyopathy. She discusses recent clinical trial data, exciting ongoing clinical trials. and gives an in depth overview of how to safely prescribe the first approved CMI, mavacamten, for obstructive hypertrophic cardiomyopathy.

An expert retina specialist discusses typical challenging scenarios, including step edits and inadequate responses to anti-VEGF treatment, frequently encountered in managing patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), and outlines effective strategies to address these issues.

An expert in dermatology provides insight on the development of TYK2 inhibitors for the management of plaque psoriasis and reviews treatment approaches using oral systemic therapy for patients.

An expert in cardiology provides insight on the role of cardiac myosin inhibitors for the management of oHCM, highlighting key clinical trial data and findings as well as the role of the REMS program.

An expert in pain management reviews pharmacologic and nonpharmacologic treatment approaches to care management for patients with fibromyalgia.

Dr Stein Gold discusses how plaque psoriasis impacts a patient’s quality of life, even when smaller body surface areas are affected. She reviews data on systemic therapies from head-to-head trials, as well as recent data in patients with moderate plaque psoriasis.

An expert nephrologist discusses the burden and standard of care for patients with immunoglobulin A nephropathy (IgAN), new and emerging targeted immunomodulating therapies, and considerations for treatment.

An expert cardiologist discusses personalizing treatment of heart failure, highlighting guideline-directed medical therapy and clinical trial data for sacubitril/valsartan.

An expert rheumatologist reviews current treatment options in rheumatoid arthritis, focusing on tumor necrosis factor-α inhibitors (TNFi) and the molecular signature response classifier (MSRC) test.

Dr. Raj Chovatiya, MD, PhD, reviews recent FDA approval and how addition of new treatments can improve management of vitiligo going forward.

Dr. Raj Chovatiya, MD, PhD, discusses recently approved treatments in atopic dermatitis and how these new additions could be used for newly diagnosed and previously treated patients.

Dr Nehad Soloman explores the advent of new and emerging therapies as well as advances in precision medicine for the management of rheumatology.

Paul Doghramji, MD, FAAFP, provides insight on the use of current treatment modalities for insomnia and the management of sleep disorders in primary care clinics.

Elaine M. Apperson, MD, provides key insights on the screening, diagnosis, and management of type 1 diabetes in patients.

An expert in diabetes care and education discusses considerations in the management of hypoglycemia and diabetes in school aged children.

Dr Peter Kaiser, an ophthalmologist, provides an overview of biosimilars, the regulatory pathway for their approval, and how biosimilars can aid in providing quality care to patients. Dr. Kaiser shares data with ranibizumab biosimilars in ophthalmology and discusses key differences between biosimilar and reference product studies.

Experts in gastroenterology discuss recent updates in the management of ulcerative colitis, highlighting their respective approaches to treatment.

An expert in emergency medicine reviews recent publications examining the efficacy and cost of prescription treatments in the management of opioid induced constipation.

Jerry Bagel, MD, MS, discusses the management of moderate-to-severe plaque psoriasis with a focus on newer agents currently in the drug approval pipeline.

An expert dermatologist provides insight on approaching the optimal treatment and management of vitiligo.

Experts in pulmonology provide insight on the diagnosis and optimal management of idiopathic pulmonary fibrosis (IPF).

Theresa R. Cerulli, MD, discusses current therapy options for the management of attention deficit hyperactivity disorders in the pediatric population.